Home » Healthcare » Cancer Immunotherapy Drug Discovery Outsourcing Market

Cancer Immunotherapy Drug Discovery Outsourcing Market By Target Identification and Validation (Bioinformatics Services), Biologics Development (Monoclonal Antibody Development, Bi-specific and Multi-specific Antibodies, Other Biologics), Cell Line Development and Engineering (CHO (Chinese Hamster Ovary) Cell Line Development, Engineering Immune Cells), Immune Profiling and Biomarker Discovery (Immunophenotyping, Biomarker Identification), Therapeutic Areas (Checkpoint Inhibitors, CAR-T Cell Therapies), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions) – Global Industry Insights, Trends, and Forecast, 2023-2030

Summary
Table Of Content

Market Insights

The global demand for Cancer Immunotherapy Drug Discovery Outsourcing was valued at USD 1352.8million in 2022 and is expected to reach USD 3006.9 Million in 2030, growing at a CAGR of 10.50% between 2023 and 2030.

Bioinformatics Services contribute to the Cancer Immunotherapy Drug Discovery Outsourcing Market.
The market’s dominating segment is monoclonal antibody development, and the most prominent sector is bi-specific and multi-specific antibodies.
CHO Cell Line Development is a vital market category, and Engineering Immune Cells is another significant market segment.
Immunophenotyping is a more popular subset, and biomarker identification is critical in the discovery of cancer immunotherapy medicines.
Both checkpoint inhibitors and CAR-T cell therapies are in high demand.
The Cancer Immunotherapy Drug Discovery Outsourcing Market is dominated by pharmaceutical and biotechnology corporations, with academic and research institutes also playing a significant role.
North America is expected to dominate the market in 2022, accounting for 36.2% of total revenue, while Asia Pacific is expected to rise at the quickest CAGR.
The rising number of cancer patients fuels market expansion.
The high cost of cancer immunotherapy drug discovery outsourcing is impeding market expansion.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Market Definition

The Cancer Immunotherapy Drug Discovery Outsourcing Market refers to the outsourcing of cancer immunotherapy drug discovery processes. It entails collaborating with outside companies or service providers to complete various stages of drug development, such as target identification, lead optimization, preclinical testing, and clinical trial support, with a focus on generating immunotherapeutic cancer treatments.

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Cancer Immunotherapy Drug Discovery Outsourcing Market will expand at a compound annual growth rate (CAGR) of 10.50%. From USD 1352.8 million in 2022, the market is projected to be worth USD 3006.9 million by 2030.

Cancer is a vast illness category that is the world’s second biggest cause of mortality. Cancer is caused by the proliferation of aberrant cells. These cells develop, divide, and replicate fast, invading body tissue/organs. Depending on the type and amount of aberrant cells, they might be slow or aggressive. Cancer comes in various forms, including breast, prostate, basal cell, melanoma, colon, and lung cancer, to name a few. Melanoma is the deadliest kind of cancer. In some circumstances, several medicines on the market can help reduce or eliminate the tumour. Cancer immunotherapy is one such treatment. Cancer immunotherapy prepares the immune system to combat cancer cells. It is a biological therapeutic method. Drugs used in this treatment are frequently created under contract with a clinical research institution. These institutions specialize in drug development and frequently provide these services at a lower cost than market players can accomplish in-house.

Segmentation by Target Identification and Validation

Bioinformatics Services contribute to the Cancer Immunotherapy Drug Discovery Outsourcing Market by providing experience in analyzing and interpreting large-scale biological datasets. This comprises genomic sequencing data, gene expression data, protein structure data, and other information.

Segmentation by Biologics Development

Monoclonal Antibody Development is the market’s dominant section. Monoclonal antibodies are molecules generated in a laboratory that can selectively target and attach to proteins or cells involved in cancer growth and progression.
Bi-specific and Multi-specific Antibodies are the most prominent sector in the Cancer Immunotherapy Drug Discovery Outsourcing Market.

Segmentation by Cell Line Development and Engineering

CHO Cell Line Development is a critical market segment. CHO cells are widely employed in biopharmaceutical production, including the manufacture of monoclonal antibodies and other therapeutic proteins used in cancer immunotherapy.
Engineering Immune Cells is another significant market segment.

Segmentation by Immune Profiling and Biomarker Discovery

Immunophenotyping is a more popular subset. Immunophenotyping is the characterization and study of immune cells found in a patient’s tumour or blood sample.
On the other hand, Biomarker identification is important in the discovery of cancer immunotherapy drugs.

Segmentation by Therapeutic Areas

In the Cancer Immunotherapy Drug Discovery Outsourcing Market, checkpoint inhibitors and CAR-T cell treatments are both highly sought-after areas. Checkpoint inhibitors are immunotherapies that assist the immune system in recognizing and attacking cancer cells. They’ve been utilized extensively in the treatment of numerous malignancies, with encouraging outcomes. CAR-T cell therapies, on the other hand, include selectively targeting and destroying cancer cells by altering a patient’s own immune cells. This tailored strategy has proven to be quite effective in certain types of blood cancer.

Segmentation by End-User

Pharmaceutical and biotechnology companies dominate the Cancer Immunotherapy Drug Discovery Outsourcing Market. These firms have the resources, experience, and infrastructure necessary to drive drug discovery and development procedures.
CROs are major players in the outsourcing market because they offer specialized services like as preclinical and clinical trials, regulatory support, and data analysis.
Academic and research institutions also play an important role in the outsourcing of cancer immunotherapy medication discovery.

Segmentation by Region

North America dominated the market in 2022, accounting for 36.2% of total revenue.
Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period.
The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Cancer Immunotherapy Drug Discovery Outsourcing.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

In 2022, North America led the market. This market is expected to expand due to the presence of numerous pharmaceutical and biotech businesses, as well as significant CROs, in the region. Furthermore, the presence of key market participants in the region, as well as government support for cancer immunotherapy drug discovery outsourcing, is encouraging market expansion.

Moreover, during the projection period, Asia Pacific is expected to develop at the quickest CAGR. This is due to an increase in the number of CROs offering cost-effective drug discovery services, an increase in the usage of modern technology, and a large number of market players effectively complying with Good Laboratory Practices (GLP) and regulatory norms.

Key Highlights of the Report

The global Cancer Immunotherapy Drug Discovery Outsourcing Market is segmented by Target Identification and Validation, Biologics Development, Cell Line Development and Engineering, Immune Profiling and Biomarker Discovery, End-User, Quality Control and Assurance, Technology Platforms and region. The market’s major segment is Monoclonal Antibody Development, with Immunophenotyping being a more popular subgroup. In addition, checkpoint inhibitors and CAR-T cell therapies are both in great demand. Furthermore, academic and research institutions are crucial in the outsourcing of cancer immunotherapy medicine discovery, with North Amerca leading the market growth.

The primary drivers of the market are rising demand for tailored and targeted cancer immunotherapies, increased demand for specialized knowledge and resources in drug discovery, and advancements in technology and scientific understanding of cancer immunotherapy. Furthermore, the primary market barriers are regulatory challenges and compliance requirements in drug development, intellectual property concerns and potential disputes in collaborations, and high costs associated with drug discovery and development procedures.

Nonetheless, North America will lead the market in 2022. The presence of multiple pharmaceutical and biotech companies, as well as important CROs, in the region is projected to drive growth in this market. Furthermore, Asia Pacific is predicted to grow at the fastest CAGR during the projection period.

What Elements Are Driving the Global Market for Cancer Immunotherapy Drug Discovery Outsourcing?

Several variables influence the Cancer Immunotherapy Drug Discovery Outsourcing Market. Cancer immunotherapies that are individualized and targeted are in high demand. Patients and doctors are looking for novel medicines that can specifically target cancer cells while causing minimal harm to healthy cells. Furthermore, there is an increasing demand for specialized skills and resources in drug discovery. Outsourcing drug discovery procedures enables corporations to tap into the knowledge and capabilities of specialist service providers, resulting in the development of new therapeutics being sped up.

What Are The Main Obstacles That The Global Cancer Immunotherapy Drug Discovery Outsourcing Market Faces?

While the Cancer Immunotherapy Drug Discovery Outsourcing Market offers numerous benefits, it also has certain drawbacks to consider. One significant barrier in drug development is the regulatory landscape and compliance requirements. It can be difficult and time-consuming to ensure that outsourced activities adhere to tight regulatory standards. Another constraint is the possibility of intellectual property issues and partnership difficulties. It might be difficult to protect intellectual property rights and prove clear ownership.

What Market Development Prospects Are There For Cancer Immunotherapy Drug Discovery Outsourcing Globally?

There are also various intriguing chances in the Cancer Immunotherapy Drug Discovery Outsourcing Market. Partnerships and collaborations between pharmaceutical corporations and service providers have the potential to grow. Companies can utilize each other’s capabilities and resources to boost innovation and accelerate drug discovery by joining forces. Furthermore, using artificial intelligence (AI) and machine learning (ML) into drug discovery methods opens up new avenues. AI and machine learning algorithms can scan massive volumes of data and uncover trends that could lead to advances in cancer immunotherapy.

Market Drivers

The global Cancer Immunotherapy Drug Discovery Outsourcing Market is driven by several factors. The following are the key drivers of the global Cancer Immunotherapy Drug Discovery Outsourcing Market:

Growing Number Of Cancer Patients

The growing tendency of sedentary lifestyles and bad diets has resulted in an increase in the number of cancer patients. The rising intake of sugary processed foods and beverages has contributed to an increase in the number of cancer patients. The increased senior population has contributed to an increase in the number of cancer sufferers. The increased intake of alcohol and tobacco has also contributed considerably to the growing number of sufferers. Skin cancer and lung cancer are both increased by exposure to UV radiation and hazardous chemicals. Various treatments are being used to treat an increasing number of cancer patients, which will drive the worldwide cancer immunotherapy drug discovery outsourcing market. Increased understanding of cancer origins, symptoms, and treatments, including new immunotherapy and medications, will further contribute to the market’s expansion.

Market Restraints

The global Cancer Immunotherapy Drug Discovery Outsourcing Market faces some challenges that may hinder its growth. These include the following:

Cancer Immunotherapy Drug Discovery Outsourcing Is Costly

A large amount of money is spent on developing medications and therapies for cancer. Market participants employ cutting-edge technology and ideas to improve the efficacy and safety of medications, cures, and treatments. Such technologies are costly, making treatments expensive. The rigorous and various rounds of testing and regulatory clearances raise the company’s costs even further. The high costs of cancer immunotherapy drug discovery outsourcing therapies will stymie industry growth.

Opportunities

The global Cancer Immunotherapy Drug Discovery Outsourcing Marketoffers significant growth opportunities. These include the following:

Increased Technological Improvements, Scientific Breakthroughs, And R&D

As the need for cancer therapies grows, key firms are investing more in developing better diagnostics, medications, devices, technologies, and treatment alternatives. The increased awareness of cancer immunotherapy drug discovery outsourcing has created new opportunities for market participants. The emergence of contract research businesses to deliver expanded services at cheaper costs and with greater competence has opened up new opportunities for market participants. increasing government investment for the development of better public healthcare infrastructure has contributed to increasing public healthcare industry research for better treatment alternatives. To grab a big market in emerging economies, major market players are collaborating and partnering to create better technology and diagnosis for cancer immunotherapy drug discovery outsourcing. Other innovations and advancements in the cancer immunotherapy drug discovery outsourcing market will make the sector more competitive and efficient, providing the required impetus to its growth and profitable prospects for market participants.

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Players

The global Cancer Immunotherapy Drug Discovery Outsourcing Marketis highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Covance, Inc.
Explicyte
Aquila BioMedical
Horizon Discovery Group PLC
Crown Bioscience, Inc.
Promega Corporation
HD Biosciences Co., Ltd.
BPS Bioscience, Inc.
Genscript Biotech Corporation
DiscoverX Corporation
Celentyx Ltd.
ImmunXperts SA
Personalis, Inc.
STC Biologics
Molecular Imaging, Inc.

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Cancer Immunotherapy Drug Discovery Outsourcing Market’s key players continually seek to stay ahead by offering new Target Identification and Validations and developments.

In February 2023, Personalis, Inc. and Moderna, Inc. announced a new collaboration to employ the Personalis NeXT Platform in upcoming clinical trials of mRNA-4157/V940, an investigational personalized cancer vaccine developed by Moderna and Merck. The technology will be used to sequence genomic data from a patient’s tumour sample in order to identify the specific genetic abnormalities that are most likely to result in a customized anticancer response.

In May 2022, Gen-Script Bio-tech Corporation and Singapore Institute of Technology (SIT) signed a Memorandum of Understanding (MOU) to develop CET, work-study degree programs, and applied research projects. This collaboration provides SIT students with worldwide biotechnology experience as well as industry competencies.

Summary of Key Findings

The high cost of cancer immunotherapy drug discovery outsourcing is impeding market expansion.

Market segmented by Target Identification and Validation, Biologics Development, Cell Line Development and Engineering, Immune Profiling and Biomarker Discovery, Therapeutic Areas, End-User and region
CHO Cell Line Development is an important market category, as is Engineering Immune Cells.
Monoclonal Antibody Development is the market’s most important segment
The Metabolite Profiling category is growing at the fastest rate.
North America is leading market growth; the market is highly competitive with key players including Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience.

Future Outlook

Increasing demand for novel cancer immunotherapies.
A growing trend for outsourcing drug discovery processes.
Increase in cooperation between pharmaceutical corporations and service providers.
Technological advances are increasing the efficiency of drug discovery.
Market expansion for specialist service providers.
Concentrate on tailored and targeted immunotherapies.

Segmentation

By Target Identification and Validation:
- Bioinformatics Services
By Biologics Development:
- Monoclonal Antibody Development
- Bi-specific and Multi-specific Antibodies
- Other Biologics
By Cell Line Development and Engineering:
- CHO (Chinese Hamster Ovary) Cell Line Development
- Engineering Immune Cells
By Immune Profiling and Biomarker Discovery:
- Immunophenotyping
- Biomarker Identification
By Therapeutic Areas:
- Checkpoint Inhibitors
- CAR-T Cell Therapies
By End-User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutions
By Region
- North America
  - The U.S.
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - The U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Cancer Immunotherapy Drug Discovery Outsourcing Market
2.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation
2.1.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development
2.1.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering
2.1.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery
2.1.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas
2.1.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User
2.1.7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
3.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
3.2.3. Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunities
3.2.4. Major Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Target Identification and Validation
3.5.2. Biologics Development
3.5.3. Cell Line Development and Engineering
3.5.4. Immune Profiling and Biomarker Discovery
3.5.5. Therapeutic Areas
3.5.6. End-User
3.5.7. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Company Market Share, Value 2022
4.1.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Top 3 Company Market Share, Value 2022
4.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type Matrix
4.7. Potential for New Players in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Engineering Immune Cells in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Cancer Immunotherapy Drug Discovery Outsourcing Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type Mix
7.2.4. Reduced Engineering Immune Cells Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation
8.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, By Target Identification and Validation
8.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Target Identification and Validation, 2022 Vs 2030 (in %)
8.2. Bioinformatics Services
8.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By BIOINFORMATICS SERVICES, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for BIOINFORMATICS SERVICES
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development
9.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, By Biologics Development
9.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Biologics Development, 2022 Vs 2030 (in %)
9.2. Monoclonal Antibody Development
9.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Monoclonal Antibody Development, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Monoclonal Antibody Development
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Bi-specific and Multi-specific Antibodies
9.3.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Bi-specific and Multi-specific Antibodies, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Bi-specific and Multi-specific Antibodies
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Other Biologics
9.4.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Other Biologics, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Other Biologics
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering
10.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, By Cell Line Development and Engineering
10.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Cell Line Development and Engineering, 2022 Vs 2030 (in %)
10.2. CHO (Chinese Hamster Ovary) Cell Line Development
10.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By CHO (Chinese Hamster Ovary) Cell Line Development, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for CHO (Chinese Hamster Ovary) Cell Line Development
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Engineering Immune Cells
10.3.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Engineering Immune Cells, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Engineering Immune Cells
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery
11.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, By Immune Profiling and Biomarker Discovery
11.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Immune Profiling and Biomarker Discovery, 2022 Vs 2030 (in %)
11.2. Immunophenotyping
11.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immunophenotyping, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Immunophenotyping
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Biomarker Identification
11.3.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biomarker Identification, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Biomarker Identification
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas
12.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, By Therapeutic Areas
12.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Therapeutic Areas, 2022 Vs 2030 (in %)
12.2. Checkpoint Inhibitors
12.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Checkpoint Inhibitors, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Checkpoint Inhibitors
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. CAR-T Cell Therapies
12.3.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By CAR-T Cell Therapies, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for CAR-T Cell Therapies
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User
13.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, By End-User
13.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
13.2. Pharmaceutical and Biotechnology Companies
13.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Pharmaceutical and Biotechnology Companies
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Contract Research Organizations (CROs)
13.3.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Contract Research Organizations (CROs), By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Contract Research Organizations (CROs)
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Academic and Research Institutions
13.4.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Academic and Research Institutions, By Region, 2017-2030 (US$ Mn)
13.4.2. Market Dynamics for Academic and Research Institutions
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends
14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region
14.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview, by Region
14.1.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region, 2022 vs 2030 (in%)
14.2. Target Identification and Validation
14.2.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030 (US$ Mn)
14.3. Biologics Development
14.3.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030 (US$ Mn)
14.4. Cell Line Development and Engineering
14.4.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030 (US$ Mn)
14.5. Toxicology Studies
14.5.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2030 (US$ Mn)
14.6. Immune Profiling and Biomarker Discovery
14.6.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030 (US$ Mn)
14.7. Therapeutic Areas
14.7.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030 (US$ Mn)
14.8. End-User
14.8.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030 (US$ Mn)
15. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030(US$ Mn)
15.7.1. Overview
15.7.2. SRC Analysis
15.8. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030(US$ Mn)
15.8.1. Overview
15.8.2. SRC Analysis
15.9. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2030(US$ Mn)
15.9.1. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
15.9.2. U.S.
15.9.3. Canada
15.9.4. Mexico
16. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
16.8.1. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
16.8.2. UK
16.8.3. France
16.8.4. Germany
16.8.5. Italy
16.8.6. Spain
16.8.7. Benelux
16.8.8. Russia
16.8.9. Rest of Europe
17. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
17.9.1. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
17.9.2. China
17.9.3. Japan
17.9.4. India
17.9.5. South Korea
17.9.6. South East Asia
17.9.7. Rest of Asia Pacific
18. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
18.9.1. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
18.9.2. Brazil
18.9.3. Argentina
18.9.4. Rest of Latin America
19. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
19.9.1. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
19.9.2. UAE
19.9.3. Saudi Arabia
19.9.4. Rest of Middle East
20. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2030 (US$ Mn)
20.8.1. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2022 Vs 2030 (in%)
20.8.2. South Africa
20.8.3. Egypt
20.8.4. Rest of Africa
21. Company Profiles
21.1. Covance, Inc.
21.1.1. Company Overview
21.1.2. Types/Services Portfolio
21.1.3. Geographical Presence
21.1.4. SWOT Analysis
21.1.5. Financial Summary
21.1.5.1. Market Revenue and Net Profit (2019-2022)
21.1.5.2. Business Segment Revenue Analysis
21.1.5.3. Geographical Revenue Analysis
21.2. Explicyte
21.3. Aquila BioMedical
21.4. Horizon Discovery Group PLC
21.5. Crown Bioscience, Inc.
21.6. Promega Corporation
21.7. HD Biosciences Co., Ltd.
21.8. BPS Bioscience, Inc.
21.9. Genscript Biotech Corporation
21.10. DiscoverX Corporation; Celentyx Ltd.
21.11. ImmunXperts SA
21.12. Personalis, Inc.
21.13. STC Biologics
21.14. Molecular Imaging, Inc.
22. Research Methodology
22.1. Research Methodology
22.2. CHO (Chinese Hamster Ovary) Cell Line Development – Secondary Research
22.3. CHO (Chinese Hamster Ovary) Cell Line DevelopmentI – Data Modelling
22.3.1. Company Share Analysis Model
22.3.2. Revenue Based Modelling
22.4. CHO (Chinese Hamster Ovary) Cell Line DevelopmentII – Primary Research
22.5. Research Limitations
22.5.1. Assumptions

List of Figures
FIG. 1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation
FIG. 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2022 (US$ Mn)
FIG. 5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2022 (US$ Mn)
FIG. 6 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2022 (US$ Mn)
FIG. 7 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2022 (US$ Mn)
FIG. 8 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2022 (US$ Mn)
FIG. 9 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by End-User, 2022 (US$ Mn)
FIG. 10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Geography, 2022 (US$ Mn)
FIG. 11 Attractive Investment Proposition, By Target Identification and Validation, 2022
FIG. 12 Attractive Investment Proposition, By Biologics Development, 2022
FIG. 13 Attractive Investment Proposition, By Cell Line Development and Engineering, 2022
FIG. 14 Attractive Investment Proposition, By Immune Profiling and Biomarker Discovery, 2022
FIG. 15 Attractive Investment Proposition, By Therapeutic Areas, 2022
FIG. 16 Attractive Investment Proposition, By End-User, 2022
FIG. 17 Attractive Investment Proposition, by Geography, 2022
FIG. 18 Global Market Share Analysis of Key Cancer Immunotherapy Drug Discovery Outsourcing Market Manufacturers, 2022
FIG. 19 Global Market Positioning of Key Cancer Immunotherapy Drug Discovery Outsourcing Market Manufacturers, 2022
FIG. 20 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value Contribution, By Target Identification and Validation, 2022 & 2030 (Value %)
FIG. 21 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by BIOINFORMATICS SERVICES, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value Contribution, By Biologics Development, 2022 & 2030 (Value %)
FIG. 23 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Monoclonal Antibody Development, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Bi-specific and Multi-specific Antibodies, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Other Biologics, Value, 2017-2030 (US$ Mn)
FIG. 26 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value Contribution, By Cell Line Development and Engineering, 2022 & 2030 (Value %)
FIG. 27 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by CHO (Chinese Hamster Ovary) Cell Line Development, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Engineering Immune Cells, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value Contribution, By Immune Profiling and Biomarker Discovery, 2022 & 2030 (Value %)
FIG. 30 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Immunophenotyping, Value, 2017-2030 (US$ Mn)
FIG. 31 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Biomarker Identification, Value, 2017-2030 (US$ Mn)
FIG. 32 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value Contribution, By Therapeutic Areas, 2022 & 2030 (Value %)
FIG. 33 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Checkpoint Inhibitors, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by CAR-T Cell Therapies, Value, 2017-2030 (US$ Mn)
FIG. 35 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 36 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 37 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Contract Research Organizations (CROs), Value, 2017-2030 (US$ Mn)
FIG. 38 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Academic and Research Institutions, Value, 2017-2030 (US$ Mn)
FIG. 39 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 40 U.S. Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 41 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 42 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 43 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 44 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 45 France Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 46 U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 47 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 48 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 49 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 50 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 51 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 52 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 53 China Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 54 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 55 India Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 56 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 57 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 58 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 59 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 60 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 61 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 62 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 63 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 64 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 65 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 66 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 67 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 68 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 69 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)
FIG. 70 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Cancer Immunotherapy Drug Discovery Outsourcing Market
TABLE 2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Drivers Impact Analysis
TABLE 3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Market Restraints Impact Analysis
TABLE 4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Bioinformatics Services, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Bioinformatics Services, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Monoclonal Antibody Development, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Monoclonal Antibody Development, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Bi-specific and Multi-specific Antibodies, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Bi-specific and Multi-specific Antibodies, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Other Biologics, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Other Biologics, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by CHO (Chinese Hamster Ovary) Cell Line Development, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by CHO (Chinese Hamster Ovary) Cell Line Development, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Engineering Immune Cells, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Engineering Immune Cells, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Evaluating Drug Efficacy, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Evaluating Drug Efficacy, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Immunophenotyping, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Immunophenotyping, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Biomarker Identification, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Biomarker Identification, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by GMP (Good Manufacturing Practice) Production, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by GMP (Good Manufacturing Practice) Production, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Regulatory Strategy, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Regulatory Strategy, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Preparing Regulatory Documents, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Preparing Regulatory Documents, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Checkpoint Inhibitors, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Checkpoint Inhibitors, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by CAR-T Cell Therapies, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by CAR-T Cell Therapies, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Academic and Research Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Academic and Research Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 42 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 43 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 44 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 45 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 46 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 47 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 48 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 49 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 50 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 51 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 52 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 53 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 54 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Region, 2017-2022 (US$ Mn)
TABLE 55 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Region, 2023-2030 (US$ Mn)
TABLE 56 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 57 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 58 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 59 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 60 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 61 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 62 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 63 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 64 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 65 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 66 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 67 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 68 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 69 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 70 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2022 (US$ Mn)
TABLE 71 North America Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2023-2030 (US$ Mn)
TABLE 72 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 73 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 74 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 75 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 76 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 77 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 78 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 79 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 80 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 81 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 82 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 83 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 84 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 85 United States Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 86 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 87 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 88 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 89 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 90 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 91 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 92 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 93 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 94 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 95 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 96 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 97 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 98 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 99 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 100 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 101 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 102 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 103 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 104 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 105 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 106 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 107 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 108 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 109 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 110 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 111 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 112 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 113 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 114 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 115 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 116 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 117 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 118 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 119 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 120 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 121 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 122 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 123 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 124 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 125 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 126 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 127 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 128 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2017-2022 (US$ Mn)
TABLE 129 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, by Country, 2023-2030 (US$ Mn)
TABLE 130 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 131 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 132 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 133 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 134 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 135 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 136 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 137 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 138 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 139 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 140 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 141 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 142 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 143 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 144 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 145 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 146 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 147 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 148 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 149 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 150 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 151 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 152 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 153 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 154 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 155 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 156 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 157 France Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 158 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 159 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 160 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 161 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 162 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 163 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 164 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 165 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 166 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 167 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 168 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 169 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 170 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 171 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 172 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 173 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 174 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 175 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 176 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 177 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 178 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 179 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 180 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 181 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2023-2030 (US$ Mn)
TABLE 182 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 183 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 184 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 185 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 186 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 187 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 188 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 189 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 190 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 191 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 192 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 193 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 194 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 195 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 196 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 197 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 198 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 199 Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 200 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 201 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 202 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 203 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 204 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 205 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 206 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 207 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 208 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 209 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 210 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 211 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 212 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 213 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 214 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 215 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 216 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 217 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 218 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 219 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 220 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 221 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 222 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 223 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 224 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 225 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 226 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 227 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 228 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 229 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 230 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 231 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 232 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 233 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 234 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 235 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 236 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 237 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 238 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 239 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 240 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 241 Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 242 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 243 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 244 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 245 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 246 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 247 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 248 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 249 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 250 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 251 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 252 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 253 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 254 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 255 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 256 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 257 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 258 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 259 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 260 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 261 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 262 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 263 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 264 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 265 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 266 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 267 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 268 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 269 China Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 270 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 271 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 272 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 273 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 274 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 275 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 276 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 277 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 278 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 279 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 280 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 281 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 282 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 283 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 284 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 285 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 286 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 287 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 288 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 289 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 290 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 291 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 292 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 293 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 294 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 295 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 296 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 297 India Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 298 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 299 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 300 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 301 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 302 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 303 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 304 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 305 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 306 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 307 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 308 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 309 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 310 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 311 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 312 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 313 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 314 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 315 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 316 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 317 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 318 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 319 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 320 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 321 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 322 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 323 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 324 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 325 South-East Asia Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 326 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 327 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 328 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 329 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 330 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 331 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 332 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 333 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 334 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 335 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 336 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 337 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 338 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 339 Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 340 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 341 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 342 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 343 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 344 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 345 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 346 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 347 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 348 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 349 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 350 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 351 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 352 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 353 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 354 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 355 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 356 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 357 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 358 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 359 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 360 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 361 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 362 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 363 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 364 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 365 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 366 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 367 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 368 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 369 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 370 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 371 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 372 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 373 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 374 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 375 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 376 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 377 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 378 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 379 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 380 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 381 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 382 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 383 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 384 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 385 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 386 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 387 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 388 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 389 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 390 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 391 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 392 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 393 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 394 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 395 Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 396 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 397 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 398 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 399 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 400 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 401 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 402 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 403 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 404 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 405 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 406 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 407 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 408 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 409 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 410 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 411 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 412 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 413 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 414 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 415 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 416 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 417 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 418 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 419 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 420 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 421 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 422 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 423 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 424 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 425 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 426 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 427 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 428 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 429 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 430 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 431 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 432 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 433 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 434 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 435 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 436 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 437 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 438 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 439 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 440 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 441 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 442 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 443 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 444 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 445 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 446 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 447 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 448 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 449 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 450 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 451 Rest of Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 452 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 453 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 454 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 455 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 456 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 457 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 458 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 459 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 460 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 461 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical
TABLE 462 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 463 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 464 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 465 Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 466 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 467 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 468 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 469 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 470 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 471 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 472 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 473 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 474 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 475 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 476 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 477 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 478 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 479 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 480 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 481 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 482 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 483 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 484 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 485 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 486 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 487 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 488 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 489 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 490 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 491 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 492 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 493 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)
TABLE 494 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2017-2022 (US$ Mn)
TABLE 495 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Target Identification and Validation, 2023-2030 (US$ Mn)
TABLE 496 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2017-2022 (US$ Mn)
TABLE 497 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Biologics Development, 2023-2030 (US$ Mn)
TABLE 498 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2017-2022 (US$ Mn)
TABLE 499 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cell Line Development and Engineering, 2023-2030 (US$ Mn)
TABLE 500 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2017-2022 (US$ Mn)
TABLE 501 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Toxicology Studies, 2023-2030 (US$ Mn)
TABLE 502 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Immune Profiling and Biomarker Discovery, 2017-2022 (US$ Mn)
TABLE 503 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 504 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2017-2022 (US$ Mn)
TABLE 505 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By Therapeutic Areas, 2023-2030 (US$ Mn)
TABLE 506 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2017-2022 (US$ Mn)
TABLE 507 Rest of Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, By End-User, By Region, 2023-2030 (US$ Mn)

What is the current Biologics Development of the worldwide Cancer Immunotherapy Drug Discovery Outsourcing Market?

In 2022, the global Cancer Immunotherapy Drug Discovery Outsourcing Market is expected to be worth USD 1352.8 million.

What is the predicted growth rate of the Cancer Immunotherapy Drug Discovery Outsourcing Market between 2023 and 2030?

The Cancer Immunotherapy Drug Discovery Outsourcing Market is estimated to increase at a CAGR of 10.50% between 2023 and 2030, reaching USD 3006.9 Million in 2030.

Which segment has the most market share in terms of End-User?

Pharmaceutical and biotechnology companies dominate the Cancer Immunotherapy Drug Discovery Outsourcing Market.

Which Therapeutic Areas segment is predicted to grow at the most in demand over the forecast period?

checkpoint inhibitors and CAR-T cell treatments are both highly sought-after areas

What are the major market drivers of the Cancer Immunotherapy Drug Discovery Outsourcing industry?

Purchase Options

Single User

$3699

Multi User

$4699

Enterprise

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –